294 related articles for article (PubMed ID: 21301969)
21. Breast magnetic resonance imaging for preoperative locoregional staging.
Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE
Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185
[TBL] [Abstract][Full Text] [Related]
22. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
23. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
24. The influence of preoperative MRI on breast cancer treatment.
Miller BT; Abbott AM; Tuttle TM
Ann Surg Oncol; 2012 Feb; 19(2):536-40. PubMed ID: 21751044
[TBL] [Abstract][Full Text] [Related]
25. Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery.
Shin HC; Han W; Moon HG; Yom CK; Ahn SK; You JM; Kim JS; Chang JM; Cho N; Moon WK; Park IA; Noh DY
Ann Surg Oncol; 2012 Aug; 19(8):2572-9. PubMed ID: 22446897
[TBL] [Abstract][Full Text] [Related]
26. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
Rajan R; Poniecka A; Smith TL; Yang Y; Frye D; Pusztai L; Fiterman DJ; Gal-Gombos E; Whitman G; Rouzier R; Green M; Kuerer H; Buzdar AU; Hortobagyi GN; Symmans WF
Cancer; 2004 Apr; 100(7):1365-73. PubMed ID: 15042669
[TBL] [Abstract][Full Text] [Related]
27. Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy.
Joh JE; Esposito NN; Kiluk JV; Laronga C; Khakpour N; Soliman H; Catherine Lee M
Breast J; 2012; 18(6):569-74. PubMed ID: 23034096
[TBL] [Abstract][Full Text] [Related]
28. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].
Sinn HP; Schmid H; Junkermann H; Huober J; Leppien G; Kaufmann M; Bastert G; Otto HF
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):552-8. PubMed ID: 8001751
[TBL] [Abstract][Full Text] [Related]
29. [Response evaluation with mammography and ultrasound].
Junkermann H; Schmid H; Sinn HP; Wallwiener D
Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
[No Abstract] [Full Text] [Related]
30. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger F; Kuerer HM; McGuire SE; Bassett R; Pusztai L; Symmans WF
Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
[TBL] [Abstract][Full Text] [Related]
31. Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.
Kim YS; Chang JM; Moon HG; Lee J; Shin SU; Moon WK
Ann Surg Oncol; 2016 Apr; 23(4):1135-42. PubMed ID: 26628432
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI.
Kim HJ; Im YH; Han BK; Choi N; Lee J; Kim JH; Choi YL; Ahn JS; Nam SJ; Park YS; Choe YH; Ko YH; Yang JH
Acta Oncol; 2007; 46(7):996-1003. PubMed ID: 17851879
[TBL] [Abstract][Full Text] [Related]
34. Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation.
Kühr M; Wolfgarten M; Stölzle M; Leutner C; Höller T; Schrading S; Kuhl C; Schild H; Kuhn W; Braun M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e541-6. PubMed ID: 21664064
[TBL] [Abstract][Full Text] [Related]
35. MRI in the evaluation of breast cancer patient response to neoadjuvant chemotherapy: predictive factors for breast conservative surgery.
Nadrljanski MM; Miloševic ZC; Plešinac-Karapandžic V; Maksimovic R
Diagn Interv Radiol; 2013; 19(6):463-70. PubMed ID: 24047722
[TBL] [Abstract][Full Text] [Related]
36. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?
Wright FC; Zubovits J; Gardner S; Fitzgerald B; Clemons M; Quan ML; Causer P
J Surg Oncol; 2010 Jun; 101(7):604-10. PubMed ID: 20461768
[TBL] [Abstract][Full Text] [Related]
37. Analysis of margin index as a method for predicting residual disease after breast-conserving surgery in a European cancer center.
Bolger JC; Solon JG; Power C; Hill AD
Ann Surg Oncol; 2012 Jan; 19(1):207-11. PubMed ID: 21638098
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
[TBL] [Abstract][Full Text] [Related]
39. Standardized pretreatment breast MRI--accuracy and influence on mastectomy decisions.
Barchie MF; Clive KS; Tyler JA; Sutcliffe JB; Kirkpatrick AD; Bell LM; Banks KP; Belenkiy S; Saenger JS; Peoples GE
J Surg Oncol; 2011 Dec; 104(7):741-5. PubMed ID: 21618242
[TBL] [Abstract][Full Text] [Related]
40. [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
Wang XH; Peng WJ; Xin C; Tan HN; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):539-43. PubMed ID: 21029700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
